Dermatology outpatient clinic, Sohag University Hospital
Sohag, 82524, Egypt
NCT Number: NCT03411733
The objective of the study is to investigate prevalence of H.Pylori infection among acne vulgaris patients.
Looking for future studies?
Notify Me12 year–60 year
All sexes
Observational
Sohag, 82524, Egypt
The study included patients with acne vulgaris and healthy control participants. The study recruited both sexes, all grades of acne, adolescents and young adults.
All patients were subjected to complete history, general and skin examination Acne vlugaris Patients were classified into mild, moderate and severe according to the classification of American Academy of dermatology for acne vulgaris.
Detection of H. pylori infection:
Blood and stool samples were taken from each participant and was directly transferred to laboratory for detection of H. Pylori antigen and antibody.
An enzyme-linked immune sorbent assay (ELISA) was used for quantitative assessment of IgG antibodies against H.Pylori in human serum.
A monoclonal antibodies based enzyme-linked immunosorbent assay was used to detect H.Pylori specific antigen in stool samples.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collection of blood and stool samples from each participants for H.pylori antigen/ antibody detection
Time frame: one year
Prevalence of H.pylori infection among acne group and control group
Sohag University
Other
Prevalence of Helicobacter Pylori in Patients With Acne Vulgaris
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06561711
Helicobacter Pylori Infection, cyclopia sequence
Beijing, Beijing Municipality, China
View Trial DetailsNCT07122284
Gut Microbiota, Helicobacter Pylori Infection
Xiamen, Fujian, China
View Trial DetailsNCT06340334
Furazolidone, Helicobacter Pylori Infection
Nanjing, China
View Trial DetailsNCT06412588
Helicobacter Pylori Infection
Nanjing, Jiangsu, China
View Trial Details